Serum and Urinary Matrix Metalloproteinase-9 Concentrations in Dehydrated Horses

被引:0
|
作者
van Spijk, Julia N. [1 ,2 ]
Lo, Hsiao-Chien [1 ]
Merle, Roswitha [3 ]
Richter, Ina-Gabriele [4 ]
Diemar, Anne [4 ]
Stoeckle, Sabita D. [1 ,5 ]
Gehlen, Heidrun [1 ]
机构
[1] Free Univ Berlin, Equine Clin, D-14163 Berlin, Germany
[2] Univ Zurich, Vetsuisse Fac, Equine Dept, Winterthurerstr 260, CH-8057 Zurich, Switzerland
[3] Free Univ Berlin, Inst Vet Epidemiol & Biostat, D-14163 Berlin, Germany
[4] Res Ctr Med Technol & Biotechnol, Dept Cell Biol, D-99947 Bad Langensalza, Germany
[5] Univ Leipzig, Equine Clin, Tierkliniken 11a, Leipzig, Germany
来源
ANIMALS | 2023年 / 13卷 / 24期
关键词
matrix metalloproteinase; biomarker; renal function; dehydration; gelatinase B; equine kidney disease; MMP-9;
D O I
10.3390/ani13243776
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Simple Summary Kidney disease is difficult to diagnose since available laboratory parameters only increase later in time. Matrix metalloproteinase-9 is an enzyme found in renal tissue and increased in human kidney disease. This study evaluated serum MMP-9 (sMMP-9) and urinary MMP-9 (uMMP-9) concentrations in dehydrated horses. Horses with signs consistent with dehydration and four healthy clinic-owned horses were included. Blood and urinary samples for MMP-9 measurements were collected at admission, and after 12 h, 24 h, and 48 h. Furthermore, the serum creatinine, urea, symmetric dimethylarginine (SDMA), urine-specific gravity, urinary protein concentration, fractional sodium excretion, and urinary gamma-glutamyl transferase/creatinine ratio (uGGT/Cr) were measured. Statistical analysis included a repeated measures ANOVA and mixed linear regression model. Overall, 40 dehydrated horses were included (Acute kidney injury 1/40; elevated serum creatinine 7/40; elevated serum SDMA 11/40; elevated uGGT/Cr at presentation 5/28). In dehydrated horses, sMMP-9 concentrations were significantly higher on arrival compared to 12 h, 24 h, and 48 h. In healthy horses, sMMP-9 showed no differences over time or compared to patients. Urinary casts and uGGT/Cr correlated with sMMP-9. Serum urea was associated with uMMP-9/Cr. In conclusion, sMMP-9 was elevated at arrival in dehydrated patients compared to later measurements. Correlations to uGGT/Cr and urinary casts need further evaluation.Abstract Matrix metalloproteinase-9 is increased in renal tissue in human kidney disease, but its role as a biomarker for kidney disease has not been fully evaluated yet. The aim of this study was to evaluate serum MMP-9 (sMMP-9) and urinary MMP-9 (uMMP-9) concentrations in dehydrated horses. Dehydrated horses were prospectively included. Blood and urinary samples were taken at admission, and after 12, 24, and 48 h (t0, t12, t24, t48), an anti-equine MMP-9 sandwich ELISA was used. Four healthy horses served as the controls. Serum creatinine, urea, symmetric dimethylarginine (SDMA), urine-specific gravity, urinary protein concentration, fractional sodium excretion, and urinary gamma-glutamyl transferase/creatinine ratio (uGGT/Cr) were measured. Statistical analysis included a repeated measures ANOVA and mixed linear regression model. Overall, 40 dehydrated horses were included (mild dehydration 13/40, moderate 16/40, severe 11/40). Acute kidney injury was found in 1/40 horses; 7/40 horses showed elevated serum creatinine, 11/40 horses elevated serum SDMA, and 5/28 elevated uGGT/Cr at presentation. In dehydrated horses, sMMP-9 concentrations were significantly higher on t0 (median: 589 ng/mL, range: 172-3597 ng/mL) compared to t12 (340 ng/mL, 132-1213 ng/mL), t24 (308 ng/mL, 162-1048 ng/mL), and t48 (258 ng/mL, 130-744 ng/mL). In healthy horses, sMMP-9 (239 ng/mL, 142-508 ng/mL) showed no differences over time or compared to patients. uMMP-9 and uMMP-9/creatinine did not differ over time or to the controls. No differences were found between dehydration groups. Urinary casts (p = 0.001; estimate = 135) and uGGT/Cr (p = 0.03; estimate = 6.5) correlated with sMMP-9. Serum urea was associated with uMMP-9/Cr (p = 0.01, estimate 0.9). In conclusion, sMMP-9 was elevated at arrival in dehydrated patients compared to later measurements. Correlations to uGGT/Cr and urinary casts need further evaluation.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Serum matrix metalloproteinase-9 as a potential biomarker for obstructive sleep apnea severity
    Kim, So Yeon
    Yoon, Hyunyee
    Choi, Seung Ho
    Cho, Jaeyoung
    SLEEP AND BREATHING, 2025, 29 (02)
  • [2] Expression of Matrix Metalloproteinase-9 in Gastric Cancer
    Prathipaa, R.
    Priyathersini, N.
    Thanka, J.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
  • [3] Increased expression of serum matrix metalloproteinase-9 in patients with moyamoya disease
    Fujimura, Miki
    Watanabe, Mika
    Narisawa, Ayumi
    Shimizu, Hiroaki
    Tominaga, Teiji
    SURGICAL NEUROLOGY, 2009, 72 (05): : 476 - 480
  • [4] Matrix Metalloproteinase-9 and Recovery of Acute Ischemic Stroke
    Abdelnaseer, Maged M.
    Elfauomy, Nervana M.
    Esmail, Eman H.
    Kamal, Manal M.
    Elsawy, Enji H.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2017, 26 (04) : 733 - 740
  • [5] Correlation between matrix metalloproteinase-9 and endometriosis
    Liu, Haiping
    Wang, Jianye
    Wang, Haiyu
    Tang, Ning
    Li, Yunfei
    Zhang, Yan
    Hao, Tianyu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (10): : 13399 - 13404
  • [6] Matrix Metalloproteinase-7 and Matrix Metalloproteinase-9 in Pediatric Multiple Sclerosis
    Unsal, Yilmaz
    Kivilcim, Gucuyener
    Aysegul, Atak
    Arzu, Aral
    Esra, Gurkas
    Ercan, Demir
    Ayse, Serdaroglu
    PEDIATRIC NEUROLOGY, 2012, 47 (03) : 171 - 176
  • [7] Novel Matrix Metalloproteinase-9 (MMP-9) Inhibitors in Cancer Treatment
    Rashid, Zainab Ahmed
    Bardaweel, Sanaa K.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (15)
  • [8] Modulation of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in sepsis
    Maitra, Subir R.
    Jacob, Asha
    Zhou, Mian
    Wang, Ping
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2010, 3 (03): : 180 - 185
  • [9] Matrix Metalloproteinase-9: Dual Role and Temporal Profile in Intracerebral Hemorrhage
    Chang, Jason J.
    Emanuel, Benjamin A.
    Mack, William J.
    Tsivgoulis, Giorgios
    Alexandrov, Andrei V.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2014, 23 (10) : 2498 - 2505
  • [10] Evaluation of heparanase and matrix metalloproteinase-9 in patients with cutaneous malignant melanoma
    Chen, Yanhui
    Chen, Ying
    Huang, Liyong
    Yu, Jianbin
    JOURNAL OF DERMATOLOGY, 2012, 39 (04) : 339 - 343